Ingunn Stromnes

13PUBLICATIONS
62CO-AUTHORS
Molecular targetsTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Tissue engineeringCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 15, 2026
<i>Sleeping Beauty</i> mutagenesis identifies <i>BACH2</i> and other regulators of CD8<sup>+</sup> T-cell exhaustion, persistence in vivo, and CAR-T cell function under tumor-associated chronic antigen stimulation.

|Jun 26, 2026
T<sub>reg</sub> cells promote immunotherapy-induced immune evasion by restraining CD4 T cell control of MHC-I-deficient metastatic pancreatic cancer.

|Dec 09, 2025
Functional genomics for improving adoptive T-cell transfer therapies.

Joseph G Skeate, Chang-Jung Lee, Carli Stewart

|Mar 12, 2025
IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8+ T cells Infiltrating Pancreatic Ductal Adenocarcinoma.

Zoe C Schmiechen, Hezkiel A Nanda, Adam L Burrack

|Jul 05, 2024
"Couple's Immunotherapy": Is CXCL13 at the Heart of the Prescription?

Eduardo Cruz-Hinojoza, Ingunn M Stromnes

|May 02, 2024
Trem2 Agonist Reprograms Foamy Macrophages to Promote Atherosclerotic Plaque Stability-Brief Report.

Michael T Patterson, Yingzheng Xu, Hannah Hillman

Pageof 3

Frequent Collaborators

5 joint publications

Alexander K Tsai

4 joint publications

Adam L Burrack

3 joint publications

Meagan R Rollins

3 joint publications

Zoe C Schmiechen